Press Releases

EIN Presswire

The cloud based platform combines incident reporting, inspections, risk assessments and dashboards provide a shared view of site’s safety activities.

MENAFN

(MENAFN) Germany has logged more than 12,000 applications for conscientious objector status so far this year, more than triple the number filed in all of 2025, according to a report published Tuesday by a newspaper group.

MENAFN

(MENAFN) Applications from Germans seeking to refuse military service on conscience grounds have more than tripled this year, with 12,102 filed in just eight months, surpassing the full-year totals of both 2025 and 2024, according to reports...

MENAFN

(MENAFN) Germany has recorded a significant increase in applications from people seeking exemption from military service on conscientious grounds, with more than 12,000 requests submitted during the first eight months of 2026. The number of...

EIN Presswire

The company behind HalloBatumi.de is expanding its focus toward integrated developments that combine property ownership & additional commercial revenue sources.

EIN Presswire

Acclaimed Industry Leaders from Over 20 Countries Unite to Judge the Year’s Most Outstanding Audio Storytelling NEW YORK, NEW YORK, NY, UNITED STATES, November 5, 2026 /⁨EINPresswire.com⁩/ -- The New York Festivals® Radio Awards®, celebrating 70...

GlobeNewswire, Inc.

Langenfeld, Germany --, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Booking Health, a medical travel coordination service, announces medical records review, specialist second opinions and full treatment coordination for pancreatic cancer patients seeking...

EIN Presswire

More than 100 Leading Industry Executives from Over 25 Countries Will Judge This Year's Entries NEW YORK, NEW YORK, NY, UNITED STATES, November 5, 2026 /⁨EINPresswire.com⁩/ -- The New York Festivals Television and Film Awards, celebrating 70 years...

GlobeNewswire, Inc.

Cemsidomide Phase 2 MOMENTUM Trial On Track to Complete Enrollment in 1Q 2027 with Initial ORR Data Expected in 2H 2027 Enrollment Complete for First Safety Cohort in Phase 1b Trial of Cemsidomide with Elranatamab; Progressing Additional Cohorts...

GlobeNewswire, Inc.

Completed Statistical Analyses of LEVEL Yielded a Predictive Enrichment Strategy Being Applied in Amended LEVEL-2 Protocol Company Has Been Granted a Type C Meeting with the FDA CHAPEL HILL, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tenax...

GlobeNewswire, Inc.

MILAN, Italy, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LYVA, LUYUANGroup’s global premium smart-mobility brand (HK.02451)，debuted at EICMA 2026, unveiling five concepts spanning e-Cargo bike, kickscooters, e-bikes and off-road e-motos. “We are rethinking...

GlobeNewswire, Inc.

Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q3 2026 increased by 73% year-over-year on an organic, constant-currency basis Generated record net revenue in Canada, with...

GlobeNewswire, Inc.

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in the ongoing global Phase I trial Cetuximab will be supplied by Lilly for the U.S. trial sites Cetuximab...

GlobeNewswire, Inc.

New York, Oct. 15, 2026 (GLOBE NEWSWIRE) -- VIVI Youth, an emerging global leader in women’s beauty and wellness nutrition, today announced a landmark philanthropic partnership with the national non-profit organization Pink Fund. Centered around...

EIN Presswire

Rediscovering the Power of Human Connection MIAMI, FL, FL, UNITED STATES, October 15, 2026 /⁨EINPresswire.com⁩/ -- An extraordinary celebration of creativity, emotional well-being and human connection brought women together in Miami on Saturday,...

GlobeNewswire, Inc.

AVT29 submitted to the European Medicines Agency as a line extension to the existing marketing authorization for Mynzepli® (aflibercept 2 mg) High-dose aflibercept offers the potential to reduce treatment frequency for patients with retinal...

GlobeNewswire, Inc.

CAMBRIDGE, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced two poster presentations at the...

GlobeNewswire, Inc.

FDA’s Rare Disease Evidence Principles (RDEP) process aims to provide greater speed and predictability in the review of therapies for rare diseases with significant unmet medical need Acceptance enables engagement with FDA on the data needed to...

GlobeNewswire, Inc.

Worldwide revenue of $389.9 million in the third quarter of 2026 GAAP fully diluted earnings per share of $0.33, compared to $0.41 in the third quarter of 2025 Adjusted fully diluted earnings per share of $1.68, compared to $1.27 in the third...

DVIDS - Georgia

LANDSTUHL, Germany — Three Public Health Command Europe employees recently participated in “The Stinky Cheese Man”, a Kaiserslautern Military Community community-theater production.